fda glp-1 compounding enforcement november 2025 Last month, the issued 25 warning letters to telehealth companies over what it called false or misleading claims about compounded medications Diabetes advocacy group discourages use

doi: 10.1002/jcph.211 58 SkowronskiAAMorabitoMVMuellerBRLeeSHjorthSLehmannAet al

Some clinical trials suggest combination therapy with both SGLT2 inhibitors and GLP-1 agonists may provide up to 27% total weight loss, though this approach requires careful medical supervision

Each bone broth jar makes 9.75L, just 85c per serve

Semaglutide and Metabolic Inflammation: A Cortisol Connection Chronic elevation of cortisol drives systemic inflammation, which in turn perpetuates obesity, insulin resistance, and metabolic syndrome

doi: 10.1371/journal.pone.0068626 145 OussaadaSMvan GalenKACooimanMIKleinendorstLHazebroekEJvan HaelstMMet al

Together, you can explore solutions like dietary changes or B12 supplements if needed